Navigate to Other Sector


Healthcare Newsletter – March 2018

First Novel Biologic Approval for Sun Pharma: Indian Pharma making New Inroads
Perpetuating Big Pharma Race to Lead in Regenerative Therapies
Continuing Complexity in Diabetes Market– Drugs & Diagnostic Devices
M&A – Device Companies’ interest in software & portfolio driven deals in pharma
Round-Up of Scale-up Funding for March

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons